FDA Approves ENNUMO™ (pegfilgrastim-pccg), Accord BioPharma's Second Pegfilgrastim Biosimilar to NEULASTA® (pegfilgrastim)

Approval gives Accord BioPharma the most comprehensive granulocyte colony-stimulating factor (G-CSF) biosimilar portfolio in the U.S., with two pegfilgrastim options and a filgrastim RALEIGH, N.C., July 9, 2026 /PRNewswire/ -- Accord BioPharma, the U.S. specialty division of Intas...